SynthesisFrontiers in pharmacology2019

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies.

Sara Ferraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.